Incyte Corp. (INCY)
98.91
-0.38
(-0.38%)
USD |
NASDAQ |
Dec 30, 16:00
99.01
+0.10
(+0.10%)
After-Hours: 20:00
Incyte Total Liabilities (Quarterly): 1.679B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Halozyme Therapeutics, Inc. | 1.717B |
| Pfizer Inc. | 115.64B |
| Bio-Techne Corp. | 560.33M |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.330B |
| Shareholders Equity (Quarterly) | 4.651B |
| Debt to Equity Ratio | 0.0089 |
| Current Ratio | 3.196 |
| Net Debt Paydown Yield | -0.00% |